vs
Profound Medical Corp.（PROF）与TRANSACT TECHNOLOGIES INC（TACT）财务数据对比。点击上方公司名可切换其他公司
TRANSACT TECHNOLOGIES INC的季度营收约是Profound Medical Corp.的1.9倍（$11.5M vs $6.0M）
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
该公司相关归属主体罗珀技术公司是一家控股集团，主要投资控股科技领域的各类企业，业务覆盖多个科技细分赛道，依托旗下子公司开展多元化科技业务布局。
PROF vs TACT — 直观对比
营收规模更大
TACT
是对方的1.9倍
$6.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.0M | $11.5M |
| 净利润 | $-8.2M | — |
| 毛利率 | 66.8% | 47.6% |
| 营业利润率 | -123.3% | -10.1% |
| 净利率 | -136.8% | — |
| 营收同比 | — | 11.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.27 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PROFTACT
| Q4 25 | $6.0M | $11.5M | ||
| Q3 25 | $5.1M | $13.2M | ||
| Q2 25 | $2.0M | $13.8M | ||
| Q1 25 | $2.3M | $13.1M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | — | $10.9M | ||
| Q2 24 | — | $11.6M | ||
| Q1 24 | — | $10.7M |
净利润PROFTACT
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $-8.0M | $15.0K | ||
| Q2 25 | $-15.7M | $-143.0K | ||
| Q1 25 | $-10.7M | $19.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-551.0K | ||
| Q2 24 | — | $-319.0K | ||
| Q1 24 | — | $-1.0M |
毛利率PROFTACT
| Q4 25 | 66.8% | 47.6% | ||
| Q3 25 | 77.7% | 49.8% | ||
| Q2 25 | 81.7% | 48.2% | ||
| Q1 25 | 79.2% | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
营业利润率PROFTACT
| Q4 25 | -123.3% | -10.1% | ||
| Q3 25 | -176.2% | 0.1% | ||
| Q2 25 | -696.9% | -1.9% | ||
| Q1 25 | -477.0% | -0.1% | ||
| Q4 24 | — | -10.3% | ||
| Q3 24 | — | -7.7% | ||
| Q2 24 | — | -3.8% | ||
| Q1 24 | — | -12.2% |
净利率PROFTACT
| Q4 25 | -136.8% | — | ||
| Q3 25 | -157.7% | 0.1% | ||
| Q2 25 | -792.3% | -1.0% | ||
| Q1 25 | -458.1% | 0.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | — | -9.7% |
每股收益（稀释后）PROFTACT
| Q4 25 | $0.27 | $-0.11 | ||
| Q3 25 | $0.26 | $0.00 | ||
| Q2 25 | $0.52 | $-0.01 | ||
| Q1 25 | $0.36 | $0.00 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | — | $-0.06 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $59.7M | $20.4M |
| 总债务越低越好 | $4.5M | — |
| 股东权益账面价值 | $66.4M | $31.1M |
| 总资产 | $77.5M | $44.8M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资PROFTACT
| Q4 25 | $59.7M | $20.4M | ||
| Q3 25 | $24.8M | $20.0M | ||
| Q2 25 | $35.2M | $17.7M | ||
| Q1 25 | $46.4M | $14.2M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $11.1M | ||
| Q1 24 | — | $10.6M |
总债务PROFTACT
| Q4 25 | $4.5M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $4.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PROFTACT
| Q4 25 | $66.4M | $31.1M | ||
| Q3 25 | $32.1M | $31.8M | ||
| Q2 25 | $39.3M | $31.3M | ||
| Q1 25 | $50.8M | $30.9M | ||
| Q4 24 | — | $30.6M | ||
| Q3 24 | — | $38.4M | ||
| Q2 24 | — | $38.5M | ||
| Q1 24 | — | $38.6M |
总资产PROFTACT
| Q4 25 | $77.5M | $44.8M | ||
| Q3 25 | $42.3M | $45.0M | ||
| Q2 25 | $49.7M | $44.5M | ||
| Q1 25 | $60.9M | $44.2M | ||
| Q4 24 | — | $44.0M | ||
| Q3 24 | — | $50.5M | ||
| Q2 24 | — | $50.4M | ||
| Q1 24 | — | $51.9M |
负债/权益比PROFTACT
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $609.0K |
| 自由现金流经营现金流 - 资本支出 | — | $589.0K |
| 自由现金流率自由现金流/营收 | — | 5.1% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $7.6M |
8季度趋势，按日历期对齐
经营现金流PROFTACT
| Q4 25 | $-6.6M | $609.0K | ||
| Q3 25 | $-9.6M | $3.6M | ||
| Q2 25 | $-13.7M | $3.6M | ||
| Q1 25 | $-8.3M | $-161.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $327.0K | ||
| Q2 24 | — | $636.0K | ||
| Q1 24 | — | $-1.5M |
自由现金流PROFTACT
| Q4 25 | — | $589.0K | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-171.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $259.0K | ||
| Q2 24 | — | $499.0K | ||
| Q1 24 | — | $-1.6M |
自由现金流率PROFTACT
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | -14.9% |
资本支出强度PROFTACT
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 1.0% |
现金转化率PROFTACT
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
